Nicolas Lamontagne

VP, Head of International Medical Affairs at Blueprint Medicines - Cambridge, MA, US

Nicolas Lamontagne's Colleagues at Blueprint Medicines
Rucha Gheewala

Manager, Global Regulatory Sciences

Contact Rucha Gheewala

Baptiste Dupuy

Commercial Lead - France & BeNeLux

Contact Baptiste Dupuy

Teresa Hurlbut

Sr. Manager Event Operations

Contact Teresa Hurlbut

Helen Shanahan

Senior Manager, Compensation and Mobility

Contact Helen Shanahan

Vittoria Pisano

Senior Manager, Talent/HRBP International

Contact Vittoria Pisano

View All Nicolas Lamontagne's Colleagues
Nicolas Lamontagne's Contact Details
HQ
617-374-7580
Location
Switzerland
Company
Blueprint Medicines
Nicolas Lamontagne's Company Details
Blueprint Medicines logo, Blueprint Medicines contact details

Blueprint Medicines

Cambridge, MA, US • 500 - 999 Employees
BioTech/Drugs

Blueprint Medicines develops kinase inhibitors for genomically defined cancer subsets of precision therapies, designed to allow patients to live longer and healthier lives.

Oncology drug discovery Oncology Genomically defined diseases Rare diseases Transformative drugs Robust drug pipeline Systemic mastocytosis Hepatocellular carcinoma Orphan drugs Small molecules Kinase inhibitor Personalized medicine Novel cancer therapies B2B Biotech SaaS Commercial Physical Research Biotechnology Biotech Pharmaceuticals
Details about Blueprint Medicines
Frequently Asked Questions about Nicolas Lamontagne
Nicolas Lamontagne currently works for Blueprint Medicines.
Nicolas Lamontagne's role at Blueprint Medicines is VP, Head of International Medical Affairs.
Nicolas Lamontagne's email address is ***@blueprintmedicines.com. To view Nicolas Lamontagne's full email address, please signup to ConnectPlex.
Nicolas Lamontagne works in the Research industry.
Nicolas Lamontagne's colleagues at Blueprint Medicines are Gramoz Kondakci, Ying Verdi, Rucha Gheewala, Baptiste Dupuy, Teresa Hurlbut, Helen Shanahan, Vittoria Pisano and others.
Nicolas Lamontagne's phone number is 617-374-7580
See more information about Nicolas Lamontagne